Manuel Romero Bernardez

Has grant

Associate Professor

Universidade de Santiago de Compostela
Country flagSpain

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Manuel Romero Bernardez is an Associate Professor at Universidade de Santiago de Compostela, Spain. His research primarily focuses on biofilm formation and quorum sensing, with recent publications discussing the role of AHL-based QS signaling in Escherichia coli and the development of biofilm models for antimicrobial testing. Additionally, his work includes the design of new quorum sensing inhibitors and the exploration of interkingdom signaling in microbial communities.

Recent Grants

Grant: Close

Transforming industry standards in healthcare: Connecting key UK interdisciplinary analytical platforms for biofilms across the National Biofilms Innovation Centre (NBIC), The National Physical Laboratory (NPL), the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), and the Singapore National Biofilm Centre (SNBC)

Open Date: 2021-01-01

Close Date: 2021-03-01

Grant: Close

Molecular nanomachines for photoactivated biofilm disruption

Open Date: 2020-12-01

Close Date: 2021-11-01

Grant: Close

Biofilm disruption activity of absorbent sustained action alginate and iodine combined wound dressings

Open Date: 2020-10-01

Close Date: 2021-03-01

Grant: Close

The fungal endoplasmic reticulum stress response and its role in crop yield and soil health via biofilm formation

Open Date: 2020-09-01

Close Date: 2021-03-01

Grant: Close

Development of antibiotic adjuvant therapy for P. aeruginosa infections by targeting polysaccharide production

Open Date: 2020-03-01

Close Date: 2021-12-01

Articles (10)

Year:

2025

Year:

2025

Chronic wound infections are generally of polymicrobial nature with aerobic and anaerobic bacteria, as well as fungi frequently observed in them. Wound treatment involves a series of steps, including debridement of the wound, flushing, and often the use of multiple wound dressings many of which are antimicrobial. Yet, many wound dressings are tested versus single species of planktonic microbes, which fails to mirror the real-life presence of biofilms. Aims Simple biofilm models are the first step to testing of any antimicrobial and wound dressing; therefore, the aim of this study was to develop and validate a simple polymicrobial colony biofilm wound model comprised of Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans on RPMI-1640 agar. The model was then used to evaluate the topical disinfectant chlorohexidine and four commercially available wound dressings using the polymicrobial model. The model used was as a starting point to mimic debridement in clinical care of wounds and the effectiveness of wound dressings evaluated afterwards. Methods and Results Planktonic assessment using AATCC100-2004 demonstrated that all antimicrobial wound dressings reduced the planktonic microbial burden below the limit of detection; however, when challenged with polymicrobial colony biofilms, silver wound dressings showed limited effectiveness (1–2 log CFU reductions). In contrast, a single iodine releasing wound dressing showed potent antibiofilm activity reducing all species CFUs below the limit of detection (>6–10 log) depending on the species. A disrupted biofilm model challenge was performed to represent the debridement of a wound and wound silver-based wound dressings were found to be marginally more effective than in whole colony biofilm challenges while the iodine containing wound dressing reduced microbial recovery below the limit of detection. Conclusions In this model, silver dressings were ineffective versus the whole colony biofilms but showed some recovery of activity versus the disrupted colony biofilm. The iodine wound dressing reduced the viability of all species below the level of detection. This suggests that mode of action of wound dressing should be considered for the type of biofilm challenge as should the clinical use, e.g. debridement.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (15)

Saskia Camille Flament Simon

Profesor Ayudante Doctor (PDI)

Universidade de Santiago de Compostela

SPAIN
View details

Fadi Soukarieh

Lecturer in Medicinal Chemistry

University of Sheffield

UNITED KINGDOM
View details

Alvaro Mata

Queen Mary University of London

UNITED KINGDOM
View details

Kim Hardie

Associate Professor

University of Nottingham

UNITED KINGDOM
View details

Michael Stocks

Professor

University of Nottingham

UNITED KINGDOM
View details

Rian L. Griffiths

University of Nottingham

UNITED KINGDOM
View details

Jens Andre Hammerl

Head of the Consultant Laboratory for Vibrio spp. in Food; Deputy Head of the Consilliary Laborytory for Yersinia

Federal Institute for Risk Assessment

GERMANY
View details

Cameron Alexander

Professor of Polymer Therapeutics

University of Nottingham Faculty of Sciences

UNITED KINGDOM
View details

Javier Fernández

Associate Professor

University of Oviedo

SPAIN
View details

Manuel Simões

Associate Professor with Habilitation

Universidade do Porto Faculdade de Engenharia

PORTUGAL
View details

Miguel Cámara

University of Nottingham

UNITED KINGDOM
View details

Jonas Emsley

professor of macromolecular crystallography

University of Nottingham

UNITED KINGDOM
View details

Aurélie Carlier

Associate Professor

University of Maastricht

NETHERLANDS
View details

Pratik Gurnani

University College London

UNITED KINGDOM
View details

Azucena del Carmen Mora Gutiérrez

Full Professor (Catedrática de Microbiología)

-

SPAIN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.